Cargando…

P1297: ABERRANT MYCN EXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA

Detalles Bibliográficos
Autores principales:	Vanden Bempt, M., Debackere, K., Demeyer, S., Van Thillo, Q., Meeuws, N., Cools, J., Dierickx, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428969/ http://dx.doi.org/10.1097/01.HS9.0000848052.80498.45

Ejemplares similares

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma
por: Vanden Bempt, Marlies, et al.
Publicado: (2022)

Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
por: Debackere, Koen, et al.
Publicado: (2021)

Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma
por: Helmsauer, Konstantin, et al.
Publicado: (2020)

Oncogenic Viruses and the Epigenome: How Viruses Hijack Epigenetic Mechanisms to Drive Cancer
por: MacLennan, Signe A., et al.
Publicado: (2023)

Retroviruses Hijack Chromatin Loops to Drive Oncogene Expression and Highlight the Chromatin Architecture around Proto-Oncogenic Loci
por: Pattison, Jillian M., et al.
Publicado: (2015)

Generation of the Fip1l1–Pdgfra fusion gene using CRISPR/Cas genome editing
por: Vanden Bempt, M, et al.
Publicado: (2016)

Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis
por: Liu, Liang, et al.
Publicado: (2021)

Function of Oncogene Mycn in Adult Neurogenesis and Oligodendrogenesis
por: Chen, Jiao, et al.
Publicado: (2021)

Oncogenic Hijacking of the PIN1 Signaling Network
por: Zannini, Alessandro, et al.
Publicado: (2019)

Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
por: Liu, Tingting, et al.
Publicado: (2023)

miR-511 and miR-1297 Inhibit Human Lung Adenocarcinoma Cell Proliferation by Targeting Oncogene TRIB2
por: Zhang, Chao, et al.
Publicado: (2012)

1297. Azithromycin vs Beta Lactams in Acute Exacerbations of COPD
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2021)

An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
por: Nagy, Zsuzsanna, et al.
Publicado: (2021)

MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21
por: Liu, Li, et al.
Publicado: (2017)

Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
por: Shinno, Yoshitaka, et al.
Publicado: (2022)

Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity
por: Lin, Huey-Jen, et al.
Publicado: (2022)

MYCN amplification drives an aggressive form of spinal ependymoma
por: Ghasemi, David R., et al.
Publicado: (2019)

Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia
por: Kourtis, Nikos, et al.
Publicado: (2018)

Properties of Spontaneous rpsL Mutant of Streptomyces albus KO-1297
por: Shemediuk, A. L., et al.
Publicado: (2022)

MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia
por: Astolfi, Annalisa, et al.
Publicado: (2013)

Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface
por: Massudi, Hassina, et al.
Publicado: (2023)

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
por: Buechner, J, et al.
Publicado: (2011)

EML1–ABL1 Is Activated by Coiled-Coil-Mediated Oligomerization and Induces T-Cell Acute Lymphoblastic Leukemia or Myeloproliferative Disease in a Mouse Bone Marrow Transplant Model
por: Vanden Bempt, Marlies, et al.
Publicado: (2018)

Is Cryptosporidium a hijacker able to drive cancer cell proliferation?
por: Certad, Gabriela
Publicado: (2022)

Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia
por: Vanden Bempt, Marlies, et al.
Publicado: (2018)

Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297
por: Li, Jijun, et al.
Publicado: (2017)

1297. Design and Testing of an Interactive Module for Improving Understanding and Application of Institutional Antibiograms
por: MacDougall, Conan
Publicado: (2022)

1297. Implementation of a Prosthetic Joint Infection Clinic in a Rural Setting
por: Lindsay, John D, et al.
Publicado: (2023)

HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression
por: Warburton, Alix, et al.
Publicado: (2018)

The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in mice
por: Schoof, Melanie, et al.
Publicado: (2023)

Oncogenic Herpesvirus KSHV Hijacks BMP-Smad1-Id Signaling to Promote Tumorigenesis
por: Liang, Deguang, et al.
Publicado: (2014)

Structural variation cooperates with permissive chromatin to control enhancer hijacking–mediated oncogenic transcription
por: Botten, Giovanni A., et al.
Publicado: (2023)

MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent
por: Wang, Tingting, et al.
Publicado: (2018)

The super elongation complex drives transcriptional addiction in MYCN-amplified neuroblastoma
por: Wang, Donghai, et al.
Publicado: (2023)

microRNA-1297 involves in the progression of oral squamous cell carcinoma through PTEN
por: Liang, Limin, et al.
Publicado: (2018)

1297. Characteristics for PrEP Uptake, Retention, and Discontinuation: Data From the ANCHOR Study
por: Mathur, Poonam, et al.
Publicado: (2018)

miR-1297 Suppresses Osteosarcoma Proliferation and Aerobic Glycolysis by Regulating PFKFB2
por: Pan, Xiaohui, et al.
Publicado: (2020)

Aberrant expression of ALK and EZH2 in Merkel cell carcinoma
por: Veija, Tuukka, et al.
Publicado: (2017)

Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma
por: Rasmuson, Agnes, et al.
Publicado: (2012)

MYCN and the epigenome
por: He, Stanley, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i3a32j72ievb1bnurr6qfof0ct